The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of a non-interventional study on cabozantinib in patients with advanced renal cell carcinoma after prior checkpoint inhibitor therapy (CaboCHECK).
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Genmab; MSD; Seagen
Honoraria - Advanced Accelerator Applications/Novartis; Apogepha; Asklepios Kliniken; AstraZeneca; Bayer; Bristol-Myers Squibb; Clinic of Oldenburg; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Nanobiotix; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Cor2Ed; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Onkowissen; Pfizer
Research Funding - Amgen (Inst); BMS (Inst); Ipsen (Inst); MSD Oncology (Inst); Novartis (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Pfizer
 
Martin Boegemann
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; ipsen; Janssen-Cilag; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - IPSEN (Inst); Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen-Cilag
 
Mohammad-Reza Rafiyan
No Relationships to Disclose
 
Guenter Niegisch
Honoraria - AstraZeneca; Medac; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck/Pfizer; Pfizer; Roche Pharma AG; Sanofi/Aventis
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Roche Pharma AG
 
Marco Julius Schnabel
Stock and Other Ownership Interests - BioNTech; Bristol-Myers Squibb
Honoraria - Apogepha; Bayer; Bayer; Bristol-Myers Squibb; Ipsen; Medac; Merck; MSD; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Ipsen; Merck; Pfizer
Research Funding - AstraZeneca; Ipsen; Janssen; MSD; QED Therapeutics
Travel, Accommodations, Expenses - Apogepha; Ipsen; Janssen; Pfizer
 
Anne Flörcken
Travel, Accommodations, Expenses - Ipsen; PharmaMar
 
Michael Maasberg
No Relationships to Disclose
 
Christoph Maintz
No Relationships to Disclose
 
Mark-Oliver Zahn
No Relationships to Disclose
 
Anke Wortmann
No Relationships to Disclose
 
Andreas Hinkel
Consulting or Advisory Role - Pfizer; Sanofi
Speakers' Bureau - Ipsen; MSD
Travel, Accommodations, Expenses - Janssen
 
Jochen Casper
No Relationships to Disclose
 
Christopher Darr
No Relationships to Disclose
 
Thomas Hilser
No Relationships to Disclose
 
Matthias Schulze
No Relationships to Disclose
 
Disorn Sookthai
No Relationships to Disclose
 
Caroline Schoenherr
No Relationships to Disclose
 
Philipp Ivanyi
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; DKG Krebsgesellschaft; Eisai; Id Institut; Ipsen; Medwiss-Extern; Meet the Experts Academy; Merck Serono; MSD
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; DKG Krebsgesellschaft; Ipsen; Merck Serono; MSD; Onkowissen; Pfizer; Roche
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; GlaxoSmithKline; Ipsen; Ipsen; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche
Expert Testimony - Bayer; Bristol-Myers Squibb; DKG Krebsgesellschaft; Ipsen; Merck Serono; Onkowissen; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck Serono; Novartis; PharmaMar